AssetMark Inc’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$158 Buy
+7
New +$168 ﹤0.01% 3646
2023
Q3
– Sell
-273
Closed -$14.4K – 1803
2023
Q2
$14.4K Sell
273
-486
-64% -$29.6K ﹤0.01% 1249
2023
Q1
$48.5K Buy
759
+114
+18% +$7.44K ﹤0.01% 1039
2022
Q4
$31.3K Buy
645
+191
+42% +$12K ﹤0.01% 1133
2022
Q3
$32K Buy
454
+204
+82% +$17.5K ﹤0.01% 1045
2022
Q2
$18K Buy
250
+197
+372% +$12.7K ﹤0.01% 1142
2022
Q1
$4K Buy
+53
New +$3.95K ﹤0.01% 1323

Other funds holding STAA

AssetMark Inc's STAA Position: Q3 2026 in Review

AssetMark Inc opened a new position in STAAR Surgical (STAA) in Q3 2026: 7 shares worth $158. The stake represents ﹤0.01% of the portfolio and ranks #3646 among its holdings. This is a return to the name: AssetMark Inc previously reported a position in STAA as recently as Q2 2023.

AssetMark Inc first reported a position in STAA in Q1 2022 and has held it in 7 quarters since. The position peaked at $48.5K in Q1 2023. 54 funds tracked by Wall St. Rank hold STAA as of Q3 2026.

  • AssetMark Inc held 7 shares of STAAR Surgical worth $158 as of Q3 2026.
  • STAAR Surgical was a new AssetMark Inc position in Q3 2026.
  • STAAR Surgical made up ﹤0.01% of AssetMark Inc's portfolio in Q3 2026, its #3646 holding.
  • AssetMark Inc first reported a position in STAAR Surgical in Q1 2022 and has held it in 7 quarters since.
  • AssetMark Inc's STAAR Surgical position peaked at $48.5K in Q1 2023.
  • 54 funds tracked by Wall St. Rank held STAAR Surgical as of Q3 2026.

Based on AssetMark Inc's 13F filing for Q3 2026, filed 21 Oct 2026.